🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Asumi Iesato

The Cancer Institute Hospital

ORCID: 0000-0002-5277-0678

Also affiliated with Japanese Foundation For Cancer Research

MedicineHealth ProfessionsBiochemistry, Genetics and Molecular BiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights”.

Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights

The Journal of Clinical Endocrinology & Metabolism(2021)10.1210/clinem/dgab552

N/A

0DataRank · unranked

22 citations

Stephanie Li, Giovanni Roti, Michele R. Hacker, Andrew H. Fischer, Carmelo Nucera +1 more

Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis

Molecules(2021)10.3390/molecules26103022

N/A

0DataRank · unranked

9 citations

Carmelo Nucera, Asumi Iesato

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

Thyroid(2023)10.1089/thy.2022.0597

N/A

0DataRank · unranked

11 citations

Stephanie Li, Peter M. Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler +2 more